首页> 外国专利> CRISPR/CAS9 VECTOR COMBINATION AND APPLICATION THEREOF IN GENE KNOCKOUT

CRISPR/CAS9 VECTOR COMBINATION AND APPLICATION THEREOF IN GENE KNOCKOUT

机译:CRISPR / CAS9矢量组合及其在基因敲除中的应用

摘要

Provided is an SgRNA combination, comprising an SgRNA specifically targeting the GGTA1 gene, an SgRNA specifically targeting the CMAH gene and an SgRNA specifically targeting the β4GalNT2 gene. Also provided is a CRISPR/Cas9 vector combination, comprising a GGTA1-CRISPR/Cas9 vector, a CMAH-CRISPR/Cas9 vector and a β4GalNT2-CRISPR/Cas9 vector. Also provided is an application of the CRISPR/Cas9 vector combination in knocking out the GGTA1 gene, the CMAH gene and the β4GalNT2 gene. The knockout rates of the three genes with the specifically targeted SgRNA sequences are respectively 56%, 63% and 41%. A three gene knockout pig can be obtained, wherein the three genes related to immune rejection are knocked out, and heart valves of said pig can be acquired.
机译:提供了一种SgRNA组合,其包含特异性靶向GGTA1基因的SgRNA,特异性靶向CMAH基因的SgRNA和特异性靶向β4GalNT2基因的SgRNA。还提供了CRISPR / Cas9载体组合,其包含GGTA1-CRISPR / Cas9载体,CMAH-CRISPR / Cas9载体和β4GalNT2-CRISPR/ Cas9载体。还提供了CRISPR / Cas9载体组合在敲除GGTA1基因,CMAH基因和β4GalNT2基因中的应用。具有特异性靶向的SgRNA序列的三个基因的敲除率分别为56%,63%和41%。可以获得三基因敲除的猪,其中与免疫排斥相关的三个基因被剔除,并且可以获得所述猪的心脏瓣膜。

著录项

  • 公开/公告号WO2019154437A1

    专利类型

  • 公开/公告日2019-08-15

    原文格式PDF

  • 申请/专利权人 NANJING MEDICAL UNIVERSITY;

    申请/专利号WO2019CN78060

  • 发明设计人 DAI YIFAN;YANG HAIYUAN;WANG YING;

    申请日2019-03-14

  • 分类号C12N15/113;C12N15/63;C12N15/90;C12N15/66;C12N15/877;A01K67/027;

  • 国家 WO

  • 入库时间 2022-08-21 11:53:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号